Harvard Apparatus Regenerative Technology, Inc. (NASDAQ:HART), a clinical stage biotechnology company developing regenerated organs for transplant, initially focused on the trachea, will announce results of its third quarter ended September 30, 2014 before market trading hours on Thursday, November 6, 2014. A conference call to discuss the company’s third quarter results and the company’s operations is scheduled for that same day at 11:00 AM (Eastern Time). On that call, management may take questions from the audience on any of a number of topics related to the business, including operations, plans and outlook.
Help employers find you! Check out all the jobs and post your resume.
